Regulatory T cells (Tregs) play crucial roles in maintaining immune tolerance. The transcription factor Foxp3 is a critical regulator of Treg development and function, and its expression is regulated at both transcriptional and post-translational levels. Acetylation by lysine acetyl transferases/lysine deacetylases is one of the main post-translational modifications of Foxp3, which regulate Foxp3's stability and transcriptional activity. However, the mechanism(s) by which the activities of these lysine acetyl transferases/lysine deacetylases are regulated to preserve proper Foxp3 acetylation during Treg development and maintenance of Treg function remains to be determined. Here we report that Mst1 can enhance Foxp3 stability, its transcriptional activity, and Treg function by modulating the Foxp3 protein at the post-translational level. We discovered that Mst1 could increase the acetylation of Foxp3 by inhibiting Sirt1 activity, which requires the Mst1 kinase activity. We also found that Mst1 could attenuate Sirt1-mediated deacetylation of Foxp3 through directly interacting with Foxp3 to prevent or interfere the interaction between Sirt1 and Foxp3. Therefore, Mst1 can regulate Foxp3 stability in kinase-dependent and kinase-independent manners. Finally, we showed that treatment of Mst1 Tregs 3 play very important roles in maintaining immune tolerance and homeostasis. Genetic abnormalities or environmental factors that affect development or functions of Tregs can cause or predispose to autoimmunity (1). Foxp3, a member of the Forkhead transcription factor family, is critical for the development and suppressive function of Tregs. Foxp3 initiates and maintains the expression of the Treg signature genes to guarantee the normal development and function of Tregs (2-4). Loss-of-function mutations in Foxp3 result in Treg deficiency and severe autoimmune diseases in both mouse and human (2, 4 -6). Ectopic expression of Foxp3 in naive T cells leads to their conversion to Tregs (3). Although the molecular pathways that control the expression of Foxp3 gene at the transcription level have been studied extensively, the molecular mechanism(s) underlying regulation of Foxp3 at the posttranslational level is not fully understood.
Tregs
3 play very important roles in maintaining immune tolerance and homeostasis. Genetic abnormalities or environmental factors that affect development or functions of Tregs can cause or predispose to autoimmunity (1) . Foxp3, a member of the Forkhead transcription factor family, is critical for the development and suppressive function of Tregs. Foxp3 initiates and maintains the expression of the Treg signature genes to guarantee the normal development and function of Tregs (2) (3) (4) . Loss-of-function mutations in Foxp3 result in Treg deficiency and severe autoimmune diseases in both mouse and human (2, 4 -6) . Ectopic expression of Foxp3 in naive T cells leads to their conversion to Tregs (3) . Although the molecular pathways that control the expression of Foxp3 gene at the transcription level have been studied extensively, the molecular mechanism(s) underlying regulation of Foxp3 at the posttranslational level is not fully understood.
Post-translational modifications such as acetylation, phosphorylation, and ubiquitination have been demonstrated to regulate protein stability and activity. Acetylation is important for maintaining Foxp3 protein expression levels and transcriptional activity, and consequently is also vital for Treg cell-mediated suppression (7, 8) . Tip60 and P300 acetylases can acetylate Foxp3, whereas Sirt1, an NAD ϩ -dependent lysine deacetylase, deacetylates Foxp3 (7) (8) (9) (10) (11) (12) . Mice treated with broad spectrum lysine deacetylase inhibitors such as trichostatin A-or SIRT-specific inhibitor nicotinamide all demonstrated reduced proinflammatory immune responses in colitis, arthritis, and cardiac transplantation models, resulting in lower disease scores (9, (13) (14) (15) . However, how the activities of those lysine acetyl transferases or lysine deacetylases are regulated in vivo and their importance under homeostatic conditions remain to be determined.
Mst1 encoding a serine/threonine kinase is a core component of the Hippo pathway and is involved in multiple cellular processes such as morphogenesis, cell proliferation and differentiation (16 -20) , stress response (21) , apoptosis (22) (23) (24) , and T cell egress and homing (25) (26) (27) (28) . Recently, it has been shown that Mst1 deficiency results in autoimmune diseases in both humans and mice (25, 29 -31) due to impaired development and function of Tregs (30) , demonstrating that Mst1 plays crucial roles in preventing autoimmunity. Although phosphoryla-tion of Foxo1/3 at the Forkhead domains by Mst1 augments their nuclear entry in 293T cells and granule neurons (21) , we have recently shown that Mst1 promotes Foxp3 expression at the transcription level through regulating the protein stability of Foxo1/3 by phosphorylating Foxo1/3 in T cells (30) . Foxp3 is also a Forkhead protein. Therefore, it remains unknown whether Mst1 can affect Foxp3 protein expression at the posttranslational level to regulate Treg development and function.
Here we show that Mst1 can stabilize the Foxp3 protein and increase its transcriptional activity and Treg function by modulating the protein at the post-translational level. We demonstrate that Mst1 enhances Foxp3 acetylation by inhibiting Sirt1 activity in a kinase-dependent manner. We also found that Mst1 or Mst1K59R (a kinase-inactive mutant functioning as a dominant negative form) could attenuate Sirt1-mediated Foxp3 deacetylation by preventing or interfering with the interaction between Sirt1 and Foxp3 in a kinase-independent manner. Finally, we uncovered that the suppressive function of Mst1 Ϫ/Ϫ Tregs was partially restored when they were treated with Ex-527, a Sirt1-specific inhibitor. Our results reveal a novel regulatory mechanism by which Mst1 enhances Foxp3 expression and Treg function through post-translational modification.
Experimental Procedures

Mice-Mst1
Ϫ/Ϫ mice are described in previous work (28) . All mice were maintained on a 129/Sv genetic background and raised in a specific pathogen-free facility. Experiments were conducted with consent from the Animal Care and Use Committee of the Institute of Developmental Biology and Molecular Medicine at Fudan University, Shanghai, China.
Cell Culture, Plasmids, and Antibodies-Murine embryonic fibroblasts (MEFs) were isolated from Mst1 ϩ/ϩ and Mst1 Ϫ/Ϫ mice. Human embryonic kidney 293T cells were cultured in DMEM with 10% FBS. CD4 ϩ CD25 ϩ Treg cells and Jurkat cells were cultured in RPMI 1640 with 10% FBS. Human Mst1K59R gene was derived from a human Mst1 cDNA by site-directed mutagenesis. A HA-tagged human Mst1 and Mst1K59R genes were then cloned into expression vector pCDNA3.1. The Mst1 RNA interference (shMst1) plasmid is described previously (32) . The IL-2 luciferase reporter plasmid was derived via inserting a PCR-amplified IL-2 promoter fragment (Ϫ305 to ϩ39) from Jurkat cells into a luciferase reporter vector, pGL4.20 (Promega). The plasmids expressing Foxp3, or shSirt1, or Sirt1, or Ep300 were gifts from Drs. Bin Li (Institut Pasteur of Shanghai, Chinese Academy of Sciences (CAS), Shanghai, China), Qiwei Zhai (Institute for Nutritional Sciences, CAS, Shanghai, China), and Shimin Zhao (Fudan University, Shanghai, China). Antibodies against the following proteins were used for our studies: CD4, CD25, Foxp3, IL-2, and IFN-␥ (eBioscience); CD3 and CD28 (BD Biosciences); phospho-Ser (Millipore); acetylated lysine, ubiquitin, and Sirt1 (Cell Signaling); HA and FLAG (Sigma); Myc (SC-40), GFP, and actin (Santa Cruz Biotechnology); and GAPDH (Beyotime).
Cell 
CD25
Ϫ cells were purified by depleting CD25 ϩ cells with an anti-CD25/anti-rat IgG kit (11035; Invitrogen), followed by further purification using a mouse CD4 kit. Intracellular staining for Foxp3, Il-2, and IFN-␥ was performed using a kit (00-5523; eBioscience) or as described elsewhere (33) . 7-Aminoactinomycin D (Sigma-Aldrich) was used to label dead cells. All samples were analyzed with a FACSCalibur or CyAn ADP analyzer and FlowJo software (TreeStar).
Quantitative PCR-Total RNA was extracted from purified peripheral CD4 ϩ CD25 ϩ Treg cells with TRIzol (Invitrogen). RT-PCR was carried out with TaKaRa RNA PCR kit (AMV) according to the manufacturer's instructions. Quantitative PCR reactions were performed on Mx3000P (Stratagene) with the Fast SYBR Green QPCR Master Mix (Stratagene), and data were analyzed with the MxPro software. Expression of Gapdh was used as internal control for real-time PCR. The primer sequences are as follows: Nrp1-F, 5Ј-TCCTGCGATTCGTTA-CTGCTG-3Ј; Nrp1-R, 5Ј-ACTCCTAAGACAACATCTGTG- GGG-3Ј; Pde3b-F, 5Ј-GCAACTCCTATGATGCTGCTGG-3Ј; Pde3b-R, 5Ј-CCTGCCTTTCCTTCTTTGTGG-3Ј; Gapdh-L, 5Ј-TGTTCCTACCCCCAATGTGTCC-3Ј; and Gapdh-R, 5Ј-GGAGTTGCTGTTGAAGTCGCAG-3Ј.
Treg Suppression Assay-A total of 6 ϫ 10 4 splenic CD4 ϩ CD25 Ϫ T cells labeled with CFSE were cultured with mitomycin C-treated T cell-depleted splenocytes and concanavalin A (2 mg/ml) in the presence of 3 ϫ 10 4 Tregs (spleen CD4 ϩ CD25 ϩ cells) for 72 h and then analyzed by FACS. The suppressive capacity of Tregs was calculated using the following formula:
Ϫ T cells alone)), as described previously (34) . Relative Treg suppression was calculated using the following formula: (Mst1 Ϫ/Ϫ Tregs suppressive capacity/Mst1 ϩ/ϩ Tregs suppressive capacity) ϫ 100%, respectively, in DMSO or Ex-527.
Luciferase Reporter Assay-The luciferase reporter driven by the IL-2 promoter was co-transfected with NFAT2, Foxp3, Sirt1, and Mst1 expression plasmids as indicated (see Fig. 5A ) into 293T cells using Lipofectamine 2000. Cells were harvested 40 h after transfection. Jurkat T cells were transfected with the same luciferase reporter only, or co-transfected with plasmids expressing Mst1, shMst1, Foxp3, Mst1/Foxp3, or shMst1/ Foxp3, respectively by electroporation (Pulser II, Bio-Rad). 40 h after electroporation, the cells were stimulated with PMA and ionomycin for another 6 h. Luciferase activity was analyzed as described previously (35) . ␤-gal was used for control for determining transfection efficiency.
GST Pulldown Assay-The GST-Foxp3 fusion protein (GSTFoxp3) and the His 6 -tagged Mst1 protein (His-Mst1) were expressed in Escherichia coli. The GST-Foxp3 and His-Mst1 were purified by glutathione-Sepharose 4B (GE Healthcare) or Ni-NTA Agarose (Clontech), respectively. The GST pulldown assay was performed as described previously (36) . GST and the GST-Foxp3 protein were visualized by GST antibody, and HisMst1 was detected by His antibody on Western blots.
Immunoblotting and Immunoprecipitation-Immunoblotting was performed as described previously (28) . For immunoprecipitation, the transfected 293T cells or T cells freshly isolated from mice were lysed in Nonidet P-40 lysis buffer (50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, 1 mM PMSF, 1ϫ protease inhibitors (Roche Diagnostics)). Then, Mst1 or Foxp3 proteins were immunoprecipitated from the supernatants with anti-HA, FLAG, or Myc-agarose beads or the appropriate antibodies with protein A-agarose beads and analyzed by immunoblotting. Images were collected with a Tanon-5200 or by x-ray film exposure. For quantification of protein levels, the appropriate film exposures were scanned, and the density of bands was determined with ImageJ and normalized with endogenous GAPDH or exogenous EGFP.
In Vitro Kinase Assay-Kinase assay was performed as described by Tao et al. (37) . Briefly, HA-tagged Mst1 was immunoprecipitated from the lysate of 293T cells transfected with pcDNA3.1-HA-Mst1 using anti-HA-agarose beads and incubated with 1 g of GST-Foxp3 purified from E. coli in the presence of [␥-
32 P]ATP. The reactions were subjected to SDS-PAGE followed by autoradiography to visualize signals of phosphoproteins.
Statistical Analysis-Statistical analysis was conducted using an unpaired t test by GraphPad Prism 4. A p valueϽ0.05 was considered significant. (30) . Because Foxo1/3 and Foxp3 proteins share a conserved Forkhead domain, we tested whether the Foxp3 protein could also be a substrate of the Mst1 kinase. Although we failed to detect obvious Mst1-mediated Foxp3 phosphorylation (Fig.  1A) , Foxp3 was found to be co-immunoprecipitated with Mst1 when co-transfected in 293T cells (Fig. 1, B and C) . This result was also repeated for endogenous Foxp3 and Mst1 proteins in mouse lymphoid T cells (Fig. 1D) . To assess the potential consequences of Mst1-Foxp3 interaction, we expressed exogenous GFP-Foxp3 fusion protein in WT and Mst1 Ϫ/Ϫ MEFs. We found that the GFP-Foxp3 fusion protein was located in 100% of nuclei of both WT and Mst1 Ϫ/Ϫ MEFs (Fig. 1E) , indicating that Mst1 deficiency does not affect the subcellular localization of the Foxp3 protein.
Results
Mst1 Interacts with the Foxp3 Protein-It
Mst1 Stabilizes Foxp3 Protein in Vitro and in VivoAlthough Mst1 deficiency has no effect on the Foxp3 nuclear localization, the Foxp3 protein level was higher when Foxp3 and Mst1 were co-expressed in 293T cells when compared with that in the control cells transfected with Foxp3 alone (Fig. 2A) . Conversely, the Foxp3 protein level was significantly lower in 293T cells co-transfected with Foxp3 and shMst1 (with a Mst1 knockdown plasmid) (Fig. 2B) , or Foxp3 and dominant negative Mst1K59R, than the controls (Fig. 2C) . The Foxp3 protein level was also significantly lower in Mst1-deficient Tregs (Fig. 2D) . Furthermore, the lower levels of Foxp3 proteins in Mst1 knockdown 293T cells (Fig. 2E ) or in Mst1-deficient Tregs (Fig. 2F) could be recovered when the cells were treated with MG132, a proteasome inhibitor. These results suggest that Mst1 enhances Foxp3 stability. To further confirm the effect of Mst1 on Foxp3 stability, we evaluated the degradation of Foxp3 when protein production was blocked by cycloheximide. Our results reveal that the degradation of ectopically expressed Foxp3 protein was significantly slowed in the cells co-transfected with Mst1 when treated by cycloheximide (Fig. 2G) .
Altogether, our studies show that Mst1 can up-regulate the expression of Foxp3 protein at the post-translational level, in addition to at the transcriptional level through enhancing the stability of Foxo1/3 proteins (30). Our data also suggest that the Mst1 kinase activity may be required for Mst1-mediated Foxp3 post-translational regulation (Fig. 2C) .
Mst1 Enhances Foxp3 Activity-To further investigate the effect of Mst1 protein on the function of Foxp3 protein, we first evaluated Foxp3 transcriptional repressor activity in vitro using a luciferase reporter driven by IL-2 promoter, the activity of which is repressed by Foxp3. The results show that the Foxp3 repressive activity was significantly enhanced when Foxp3 was co-expressed with Mst1 (Fig. 3A, Bar 11) , or impaired when Foxp3 was co-transfected with shMst1 to knock down endogenous Mst1 expression (Fig. 3A, Bar 12) in Jurkat T cells stimulated by PMA and ionomycin. Consistent with the above in vitro data, expression of endogenous IL-2, IFN-␥, and Pde3b genes, which were direct targets of Foxp3 and down-regulated by Foxp3, was up-regulated in Mst1 Ϫ/Ϫ Tregs (Fig. 3, B and C) . Meanwhile CD25 and Nrp1, which were up-regulated by Foxp3, were down-regulated in Mst1 Ϫ/Ϫ Tregs (Fig. 3, C and  D) . These data indicate that Mst1 enhances Foxp3 transcription activity.
Mst1 Enhances Foxp3 Acetylation-Post-translational modifications of the Foxp3 protein such as phosphorylation, acetylation, and ubiquitination affect the protein's stability and activity (7, 8, 10, 38) . Because we failed to detect obvious Mst1-mediated Foxp3 phosphorylation (Fig. 1A) Foxp3, Foxp3 and Mst1 were co-transfected into 293T cells and the Foxp3 protein was immunoprecipitated from cell lysate, followed by blotting with an anti-acetyl lysine antibody. The results show that the acetylation level of Foxp3 was increased when Mst1 was co-transfected ( Fig. 4A ), indicating that Mst1 may increase Foxp3 protein stability by enhancing Foxp3 acetylation. Acetylation of Foxp3 results in increased protein levels by preventing polyubiquitination (7, 10) . Consistent with these previous studies, we also found that expression of exogenous Mst1 reduced Foxp3 ubiquitination (Fig. 4B) , probably due to Mst1-mediated increase of Foxp3 acetylation.
Mst1 Enhances Foxp3 Acetylation and Stability by Inhibiting Sirt1
Activity-The transcription activity and stability of Foxp3 can be dynamically regulated by reversible acetylation (7, 8, 10, 38) . Sirt1 is one of the deacetylases that deacetylates Foxp3 (10) , and Sirt1's activity can be inhibited by Mst1-mediated phosphorylation (32) . Thus, we hypothesized that Mst1 enhanced Foxp3 stability by inhibiting Sirt1 activity. To test this possibility, we first examined whether Mst1 could affect Sirt1-mediated Foxp3 degradation. The results show that expression of exogenous Mst1 suppressed Sirt1-mediated Foxp3 degradation (Fig.  4C) . Then, we assessed the acetylation of Foxp3 in 293T cells expressing exogenous Ep300, Foxp3, and Sirt1 with or without Mst1 by IP-Western blot. Our study demonstrates that Mst1 could inhibit Sirt1-mediated deacetylation of the Foxp3 protein (Fig. 4D) . We also show that Mst1 was unable to further enhance acetylation of Foxp3 when Sirt1 activity was inhibited by Ex-527, a specific inhibitor for Sirt1 (Fig. 4E) . Furthermore, treatment of Ex-527 or knockdown endogenous Sirt1 was able to prevent Mst1 knockdown-mediated degradation of the Foxp3 proteins (Fig. 4, F and G) . All these data demonstrate that Mst1 enhanced Foxp3 stability by inhibiting Sirt1 activity.
Mst1 Blocks the Access of Sirt1 to Foxp3-Although Mst1 can enhance Foxp3 acetylation and stability by inhibiting Sirt1 deacetylase activity (Fig. 4, C-G) , probably through phosphorylating Sirt1, it is not clear whether Mst1 kinase activity is absolutely required for this process. To address this question, WT Mst1 or kinase-inactive Mst1K59R was co-expressed with Foxp3 in Mst1-deficient MEFs, and then Foxp3 protein level was evaluated by Western blot. The results show that Mst1K59R was able to significantly enhance Foxp3 protein level, although its effect was less strong than WT Mst1 (Fig. 5A) , suggesting that Mst1 kinase activity is not absolutely required for maintenance of Foxp3 stability. We also confirmed that expression of dominant negative Mst1K59R inhibited phosphorylation of co-expressed Sirt1 (Fig. 5B) and further showed that Mst1K59R could also effectively bind to Foxp3 or Sirt1 in transfected 293T cells (Fig. 5, C and D) . Based on these results, we proposed that binding of Mst1K59R to Foxp3 might block the access of Sirt1 to Foxp3. Indeed, we found that less Sirt1 was co-immunoprecipitated with Foxp3 from lysate of 293T cells co-expressing Mst1, Foxp3, and Sirt1 (Fig. 5E ), indicating again that Mst1 attenuates the interaction between Sirt1 and Foxp3. This result not only suggests that Mst1 and Sirt1 may compete with each other for the binding of Foxp3, but also indicates that co-immunoprecipitation of Mst1 and Foxp3 may not be due to the formation of Mst1-Sirt-Foxp3 triple complex, i.e. that Mst1 may directly interact with Foxp3. To test this possibility, we performed a pulldown assay using bacterially expressed Foxp3 and Mst1. The results demonstrate that Mst1 was able to directly interact with Foxp3 (Fig. 5F ). Thus, we conclude that Mst1 can also regulate Foxp3 stability in a kinase-independent manner.
Mst1 Promotes Foxp3 Activity and Treg Function by Suppressing Sirt1-Because the above results show that Mst1 could enhance Foxp3 protein stability by inhibiting Sirt1 activity and blocking the access of Sirt1 to Foxp3, we asked whether Mst1 could reverse Sirt1-mediated suppression of Foxp3 transcription repressor activity. To answer this question, we analyzed Sirt1's inhibition on Foxp3 activity with or without Mst1. Our study shows that when co-transfected with Mst1, the Sirt1-mediated repression of Foxp3 transcription activity was fully eliminated (Fig.  6A) . Next, we further asked whether the impaired suppressive function of Mst1 Ϫ/Ϫ Tregs was related to the increase of Sirt1 activity resulting from the loss of Mst1's inhibition on Sirt1. To address this question, we assessed the suppressive activity of Tregs was partially rescued by Ex-527 treatment (Fig. 6B) . Thus, we conclude that Mst1 promotes Foxp3 transcription activity and Treg function by inhibiting Sirt1 activity.
Discussion
Transcription factor Foxp3 is essential for the proper development and function of Tregs (39), which are important for maintaining immune homeostasis (40, 41) . Because mainte- DECEMBER 25, 2015 • VOLUME 290 • NUMBER 52 nance of Foxp3 output is crucial for Treg cell-mediated immunosuppression, Foxp3 expression is tightly controlled at the transcriptional level by multiple signaling pathways (42) (43) (44) (45) (46) . However, accumulated evidence has demonstrated that Foxp3 post-translational modification, such as ubiquitination, acetylation, and phosphorylation, also plays important roles in the control of Foxp3 protein level and Tregs functions (47) . In this study, we present for the first time evidence that Mst1 enhances the stability and transcriptional activity of Foxp3 by inhibiting Sirt1-mediated Foxp3 deacetylation not only through phosphorylating and inhibiting Sirt1, but also by directly interacting with Foxp3 and physically blocking the binding of Sirt1 to Foxp3. Our results indicate that Mst1 can also function as a "scaffold" protein to regulate protein stability through competing for protein binding in a kinase-independent manner. Thus, our study reveals a novel mechanism by which Mst1 regulates Foxp3 expression and Treg development/function by modulating Foxp3 protein stability. Because our previous studies have shown that Mst1-deficient mice are prone to autoimmune disease due to impaired Tregs and demonstrated that Mst1 upregulates Foxp3 transcription by stabilizing Foxo1/3 proteins through direct phosphorylation of Foxo1/3 proteins and indirect inhibition of Akt activity (30), we propose that Mst1 regulates Foxp3 protein expression at both transcriptional and posttranslational levels.
Mst1 Up-regulates Foxp3 Stability and Treg Functions
Several deacetylases have recently been shown to regulate Foxp3 acetylation and thereby stability and transcriptional activity (7) (8) (9) (10) (11) 47) . However, how the activities of these deacetylases are regulated in vivo, and how important they are under homeostatic conditions, remains to be determined. The results that we show here suggest that upon T cell receptor (TCR) stimulation, Mst1 enhances Foxp3 protein stability and activity by increasing acetylation of Foxp3 protein through inhibiting Sirt1 activity and interfering with Sirt1 binding to Foxp3. Therefore, Mst1-mediated post-translational modification on Foxp3 may offer a quick way to regulate the cellular protein level of Foxp3 in response to extracellular signals.
Mst1 can also regulate P53 stability and activity through inhibiting Sirt1 (32) . In this study, we have observed that Mst1-Sirt1 axis can control Foxp3 stability and activity by modifying Foxp3 acetylation. These studies provide strong evidence to support that Mst1-Sirt1 axis may be a conserved pathway regulating multiple biological processes. Therefore, our study deepens understanding of the fundamental functions mediated or controlled by the Hippo/Mst1 signaling.
Author Contributions-J. L., X. D., and W. T. designed research, J. L., X. D., and H. S. performed research, data collection, and statistical analysis, J. L., X. D., K. D., and W. T analyzed and interpreted data, and J. L., X. D., and W. T wrote the manuscript. 
